minocycline and Anaphylaxis

minocycline has been researched along with Anaphylaxis* in 5 studies

Reviews

2 review(s) available for minocycline and Anaphylaxis

ArticleYear
Intravascular catheters impregnated with antimicrobial agents: a milestone in the prevention of bloodstream infections.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1999, Volume: 7, Issue:6

    Vascular catheters impregnated with antimicrobial agents have been shown to decrease the risk of catheter-related colonization and bloodstream infections. Various antimicrobials and antiseptics have been used. In a recent meta-analysis of 12 studies, catheters coated with chlorhexidine and silver sulfadiazine (CH/SS) were shown to be significantly less likely to be associated with catheter-related bloodstream infections than uncoated catheters. However, these catheters were coated only on the external surface and they are associated with short antimicrobial durability (3-7 days). In addition, anaphylactic reactions to them were reported in Japan. Vascular catheters impregnated with minocycline and rifampin (M/R) were found to be highly efficacious in preventing catheter-related infections. In a recent prospective, randomized trial, the likelihood of catheter-related bloodstream infections associated with the use of M/R catheters was one-twelfth of that observed with catheters coated with CH/SS. The M/R catheters are coated on the external and internal surfaces and have an antimicrobial durability of 4 weeks. Although no resistance to either minocycline or rifampin has been seen in two trials, further studies are required to determine whether the risk of resistance outweighs the benefits derived from their use. In conclusion, antimicrobial catheters have been shown to be highly cost effective in decreasing the risk of catheter-related bloodstream infection.

    Topics: Anaphylaxis; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Bacteremia; Bacterial Infections; Catheters, Indwelling; Chlorhexidine; Coated Materials, Biocompatible; Enzyme Inhibitors; Humans; Minocycline; Rifampin; Risk Assessment; Risk Factors; Silver Sulfadiazine

1999
Anaphylactoid symptoms due to oral minocycline.
    Acta dermato-venereologica, 1996, Volume: 76, Issue:2

    Topics: Administration, Oral; Adult; Anaphylaxis; Anti-Bacterial Agents; Female; Humans; Minocycline; Salpingitis

1996

Other Studies

3 other study(ies) available for minocycline and Anaphylaxis

ArticleYear
Minocycline-induced anaphylaxis mediated by antigen-specific immunoglobulin E.
    The Journal of dermatology, 2022, Volume: 49, Issue:2

    Topics: Anaphylaxis; Humans; Immunoglobulin E; Mast Cells; Minocycline

2022
Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection.
    Infection, 2013, Volume: 41, Issue:2

    We report the first case of anaphylaxis to oral vancomycin in a cystic fibrosis patient with severe and relapsing Clostridium difficile infection (CDI) refractory to metronidazole. The patient's colitis has been successfully treated with a combination of intravenous metronidazole and tigecycline.

    Topics: Administration, Oral; Adult; Anaphylaxis; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cystic Fibrosis; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Minocycline; Severity of Illness Index; Tigecycline; Vancomycin

2013
A case of anaphylaxis to oral minocycline.
    Journal of Korean medical science, 2010, Volume: 25, Issue:8

    Minocycline is a semisynthetic tetracycline derivative that is often used in the treatment of acne vulgaris. To date, there has been only one case report of anaphylaxis to minocycline. We report here a case of anaphylaxis to oral minocycline. A 56-yr-old woman visited our hospital after three episodes of recurrent anaphylaxis. We performed an oral challenge test, the standard method for diagnosing drug allergies, with minocycline, one of the drugs she had taken previously. She developed urticaria, angioedema, nausea, vomiting, hypotension, and dyspnea within 4 min and was treated with intramuscular epinephrine, intravenous antihistamine and systemic corticosteroid. However, she presented similar symptoms at 50 min and at 110 min. In prescribing oral minocycline, physicians should consider the possibility of serious adverse reactions, such as anaphylaxis.

    Topics: Administration, Oral; Anaphylaxis; Anti-Bacterial Agents; Drug Hypersensitivity; Female; Humans; Middle Aged; Minocycline; Recurrence

2010